Helen Y. Chu
Helen Y. Chu | |
---|---|
Alma mater | Duke University Cornell University |
Known for | Immunology Virology |
Scientific career | |
Fields | Maternal immunization |
Institutions | University of Washington Beth Israel Deaconess Medical Center |
Thesis | A prospective study of respiratory syncytial virus infection among children attending daycare (2012) |
Helen Y. Chu is an American
Education and early career
Chu was born in Western China.[4] Her grandparents were academics in Luoyang. Her parent and grandparents were sent to work in countryside labor camps, but as her father had been born in the United States, her parents immigrated to Southern California.[4] In 2001 Chu completed her bachelor's degree at Cornell University. She spent one year as a visiting student at the University of Oxford.[4] She moved to Duke University to train in medicine. Chu was a medical resident at the Beth Israel Deaconess Medical Center. In 2009 Chu was appointed to the faculty at Harvard University, before being awarded a fellowship at the University of Washington in 2011. During the first year of her fellowship, Chu encountered the fields of public health and epidemiology through her work on Influenza A virus subtype H1N1.[4]
Research and career
Chu specializes in maternal immunization, with a particular focus on
During the
The Seattle Flu Study partnered with public health officials to launch a Seattle Coronavirus Assessment Network, who collect nasal swabs from people across Seattle in an effort to understand the spread of coronavirus disease.[9] Chu shifted her research to focus on the identification of patients who had become infected with SARS-CoV-2.[6] In early March Chu was awarded permission from the Food and Drug Administration to start COVID-19 testing.[10] She conducted an investigation into the prevalence of coronavirus disease, enrolling participants online and rapidly distributing home testing kits. Kits were delivered with same-day delivery, sometimes within hours of people registering on the site, and samples were analysed within two days.[6] Alongside her own research program to better understand the transmission and biology of SARS-CoV-2, Chu is involved with the National Institutes of Health COVID-19 vaccine trials and clinical trials into the use of antiviral drugs.[15]
Selected publications
- Steinhoff, Mark C; Katz, Joanne; Englund, Janet A; Khatry, Subarna K; Shrestha, Laxman; Kuypers, Jane; Stewart, Laveta; Mullany, Luke C; Chu, Helen Y; LeClerq, Steven C; Kozuki, Naoko (September 1, 2017). "Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial". The Lancet Infectious Diseases. 17 (9): 981–989.
- Perchetti, Garrett A; Wilcox, Naomi; Chu, Helen Y; Katz, Joanne; LeClerq, Steven C; Tielsch, James; Jerome, Keith R; Englund, Janet A; Kuypers, Jane (November 2, 2020). "Human Metapneumovirus Infection and Genotyping of Infants in Rural Nepal". Journal of the Pediatric Infectious Diseases Society. 10 (4): 408–416.
- Mazur, Natalie I; Higgins, Deborah; Nunes, Marta C; Melero, José A; Langedijk, Annefleur C; Horsley, Nicole; Buchholz, Ursula J; Openshaw, Peter J; McLellan, Jason S; Englund, Janet A; Mejias, Asuncion (October 1, 2018). "The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates". The Lancet Infectious Diseases. 18 (10): e295–e311.
- Chu, Helen Y.; Englund, Janet A. (August 15, 2014). "Maternal Immunization". Clinical Infectious Diseases. 59 (4): 560–568.
References
- ^ "Helen Y. Chu M.D., M.P.H." UW Medicine.
- ^ Fink, Sheri; Baker, Mike (March 11, 2020). "'It's Just Everywhere Already': How Delays in Testing Set Back the U.S. Coronavirus Response". The New York Times.
- ^ "Dr. Helen Chu pivoted pandemic-tracking framework when Covid-19 hit the region". www.bizjournals.com.
- ^ a b c d e Leib, Matthew Macdonald (December 12, 2019). "Faculty Friday: Helen Chu". The Whole U. Retrieved May 6, 2020.
- ^ "Chu, Helen". Department of Epidemiology. October 3, 2017. Retrieved May 6, 2020.
- ^ PMID 32356944.
- ^ a b "Helen Chu, MD, MPH: The Seattle Flu Study". HCPLive®. Retrieved May 6, 2020.
- ^ ISSN 0362-4331. Retrieved May 6, 2020.
- ^ a b "Leadership Update from the Seattle Flu Study". Leadership Update from the Seattle Flu Study. Retrieved May 6, 2020.
- ^ PMID 32152595.
- ^ "Seattle lab only uncovered extent of Washington coronavirus outbreak after breaking government rules". The Independent. March 11, 2020. Retrieved May 6, 2020.
- ^ "The Daily: Why the U.S. Wasn't Ready for the Coronavirus on Apple Podcasts". Apple Podcasts. Retrieved May 6, 2020.
- ^ Grande, Alison (May 2, 2020). "Remdesivir gets FDA approval, UW researcher reacts". KIRO. Retrieved May 6, 2020.
- ^ "How Seattle Flu Study defied federal government to test for coronavirus". MyNorthwest.com. March 12, 2020. Retrieved May 6, 2020.
- ^ "On the Ground With COVID-19 in Seattle". www.medpagetoday.com. March 3, 2020. Retrieved May 6, 2020.
- PMID 28522338.
- PMID 33137178.
- S2CID 49300571.
- PMID 24799324.